96 related articles for article (PubMed ID: 3821054)
21. Plasma catecholamines and urinary excretion of their main metabolites in three models of portal hypertension.
Rodríguez-Puyol D; Alsasua A; Santos JC; Blanchart A; López-Novoa JM
Clin Physiol Biochem; 1988; 6(6):301-9. PubMed ID: 3208482
[TBL] [Abstract][Full Text] [Related]
22. Urinary homovanillic acid, dopamine and norepinephrine excretion in patients with essential hypertension.
Gitlow SE; Dziedzic LB; Dziedzic SW
Can Med Assoc J; 1978 Jan; 118(2):125-8. PubMed ID: 757379
[No Abstract] [Full Text] [Related]
23. Pathophysiological role of dopamine on the development of hypertension in rats.
Yoshimura M; Kambara S; Okabayashi H; Ikegaiki I; Matsuzawa M; Suga K; Takahashi H; Ijichi H
Jpn Circ J; 1987 Oct; 51(10):1226-31. PubMed ID: 3430692
[TBL] [Abstract][Full Text] [Related]
24. Peripheral dopamine in essential hypertension. An early defense against hypertension failing during its progression?
Kuchel O
Am J Hypertens; 1990 Jun; 3(6 Pt 2):104S-107S. PubMed ID: 2200433
[TBL] [Abstract][Full Text] [Related]
25. Influence of dopamine agonists on plasma and brain levels of homovanillic acid.
Kendler KS; Heninger GR; Roth RH
Life Sci; 1982 Jun; 30(24):2063-9. PubMed ID: 7109836
[TBL] [Abstract][Full Text] [Related]
26. Urinary free and conjugated catecholamines and metabolites in autistic children.
Barthelemy C; Bruneau N; Cottet-Eymard JM; Domenech-Jouve J; Garreau B; Lelord G; Muh JP; Peyrin L
J Autism Dev Disord; 1988 Dec; 18(4):583-91. PubMed ID: 3215884
[TBL] [Abstract][Full Text] [Related]
27. The heterogeneity of dopamine involvement in essential hypertension.
Kuchel O
Clin Exp Hypertens A; 1989; 11 Suppl 1():217-25. PubMed ID: 2663248
[TBL] [Abstract][Full Text] [Related]
28. Circadian variations of the urinary excretion of catecholamines and electrolytes.
Faucheux B; Kuchel O; Cuche JL; Messerli FH; Buu NT; Barbeau A; Genest J
Endocr Res Commun; 1976; 3(5):257-72. PubMed ID: 991809
[TBL] [Abstract][Full Text] [Related]
29. Perinatal micronutrient supplements ameliorate hypertension and proteinuria in adult fawn-hooded hypertensive rats.
Koeners MP; Braam B; van der Giezen DM; Goldschmeding R; Joles JA
Am J Hypertens; 2010 Jul; 23(7):802-8. PubMed ID: 20360751
[TBL] [Abstract][Full Text] [Related]
30. Effect of voluntary exercise on urinary excretion of catecholamines after traumatic shock in rats.
Asoh T; Uchida I
Circ Shock; 1989 Jan; 27(1):73-81. PubMed ID: 2917374
[TBL] [Abstract][Full Text] [Related]
31. Catecholamine glucuronidation: an important metabolic pathway for dopamine in the rat.
Wang PC; Kuchel O; Buu NT; Genest J
J Neurochem; 1983 May; 40(5):1435-40. PubMed ID: 6834068
[TBL] [Abstract][Full Text] [Related]
32. Increased dopamine production in patients with carcinoid tumors.
Feldman JM
Metabolism; 1985 Mar; 34(3):255-60. PubMed ID: 3974452
[TBL] [Abstract][Full Text] [Related]
33. Effects of a false neurotransmitter, p-hydroxynorephedrine, on the function of adrenergic neurons in hypertensive patients.
Rangno RE; Kaufmann JS; Cavanaugh JH; Island D; Watson JT; Oates J
J Clin Invest; 1973 Apr; 52(4):952-60. PubMed ID: 4348345
[TBL] [Abstract][Full Text] [Related]
34. Effects of 5-hydroxytryptamine on the transintestinal electrical activity and cardiovascular function of fawn-hooded rats in-vivo.
Hardcastle J; Hardcastle PT
J Pharm Pharmacol; 1999 Dec; 51(12):1415-21. PubMed ID: 10678497
[TBL] [Abstract][Full Text] [Related]
35. Suppression of norepinephrine secretion by dopamine in children with neuroblastoma: evidence for precursor inhibition in catecholamine pathway.
Sato T; Minami S; Igarashi N; Miyagawa K
Endocrinol Jpn; 1989 Aug; 36(4):595-603. PubMed ID: 2583066
[TBL] [Abstract][Full Text] [Related]
36. Effects of debrisoquin on the excretion of catecholamine and octopamine metabolites in the rat and guinea pig.
Edwards DJ; Ravitch J; Knopf S
Biochem Pharmacol; 1985 Aug; 34(16):2911-6. PubMed ID: 3896245
[TBL] [Abstract][Full Text] [Related]
37. The significance of duration of salt loading on cardiovascular response and urinary excretion of catecholamine in rats.
Yoshimura M; Yamazaki H; Takashina R; Kambara S; Iyoda I; Sasaki S; Takahashi H; Takeda K; Ijichi H
Endocrinol Jpn; 1986 Apr; 33(2):169-75. PubMed ID: 3757915
[TBL] [Abstract][Full Text] [Related]
38. Enhanced renal sympathetic nerve activity in response to salt loading in rats.
Yamazaki H; Yoshimura M; Kambara S; Lee LC; Fukuyama M; Sasaki S; Takahashi H; Takeda K; Ijichi H
Jpn Circ J; 1986 May; 50(5):442-8. PubMed ID: 2876114
[TBL] [Abstract][Full Text] [Related]
39. Influence of amineptine on changes of blood pressure evoked by norepinephrine and dopamine.
Lim DY; Lee KJ; Kim SH; Kim BH; Lee JJ; Lee EH; Chang KS; Hong SP
Korean J Intern Med; 1991 Jul; 6(2):69-78. PubMed ID: 1807368
[TBL] [Abstract][Full Text] [Related]
40. An increase in urinary catecholamines of renal origin in patients with "borderline" hypertension.
Kuchel O; Cuche JL; Buu NT; Genest J
Am J Med Sci; 1976; 272(3):263-8. PubMed ID: 1015511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
